Skip navigation

Calls to Action

autism treatments

Can Translational Neuroscience Deliver Effective Treatments for Autism?

IMFAR keynote speaker identifies barriers to delivering better treatments and how international collaboration can break the logjam
May 15, 2014

Neurodevelopmental psychiatrist Declan Murphy, of King’s College London, delivered the first keynote address of the 2014 International Meeting for Autism Research (IMFAR) today in Atlanta.

Autism Speaks Awards Nearly $2.7 Million for New Research Projects

Latest Funding Invests in Potential Treatments for Autism Spectrum Disorder, Early Access to Care and Research into Environmental Risk Factors

Autism Speaks announced the award of nearly $2.7 million for the funding of 13 new research projects over the next three years.

January 06, 2014

NEW YORK, N.Y. (January 6, 2014) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced the award of nearly $2.7 million for the funding of 13 new research projects over the next three years. These grants will address Autism Speaks’ Early Access to Care initiative to reduce the average age of diagnosis and increase access to high-quality early intervention for all children affected by autism spectrum disorders (ASD).

Day 3 at Neuroscience 2013: Spotlight on Experimental Autism Treatments

Researchers discuss early findings on diverse experimental treatments – medicines, stem cell therapy, brain stimulation and more
November 12, 2013

Neuroscience 2013: Q&A with NIMH Chief Tom Insel

The director of the National Institutes of Mental Health discusses the future of autism diagnosis, treatment and research
November 11, 2013

Following a National Institutes of Health press conference at Neuroscience 2013, in San Diego, National Institute of Mental Health Director Tom Insel sat down with Autism Speaks to talk about the future of autism research, diagnosis and treatment.


Autism Speaks Names New Head of Medical Research

Pediatrician-scientist Paul Wang will oversee organization’s portfolio of medical research with emphasis on clinical studies
September 30, 2013

Behavioral-developmental pediatrician Paul Wang has joined Autism Speaks as its new senior vice president and head of medical research. He will oversee the organization’s medical research portfolio, with a strong focus on clinical studies.  

Oxytocin May Control Brain’s ‘Signal-to-Noise’ Filter

Study findings on so-called "social hormone" could explain autism-related differences in information processing
August 05, 2013

Many persons with autism have sensory difficulties. These include challenges with focusing attention on important information while screening out background activity.